Qingfeng Zou

Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women

De‐Shen Wang, Ming-Tao Hu, Zhi‐Qiang Wang et al. · JAMA Network Open · 2021 · 31 citations · Full text

S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.

Rui‐Hua Xu, Zhi‐Qiang Wang, Lin Shen et al. · Journal of Clinical Oncology · 2019 · 23 citations

Surgical Oncology, Mixed-type Gastric Adenocarcinoma, Esophageal Cancer +15

Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

Yuqin Song, Hui Zhou, Huilai Zhang et al. · Advances in Therapy · 2021 · 18 citations

Hematological Malignancy, Rituximab Plus Chop, Lymphoid Neoplasia +8

Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors

Chihiro Hata, Hirofumi Nakaoka, Yu Xiang et al. · Journal of Human Genetics · 2020 · 16 citations

Prognostic Factors, Breast Oncology, Oncology +10

LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins

Ye Song, Jike Du, Pinglan Lu et al. · Annals of Translational Medicine · 2021 · 16 citations · Full text